Home | Cancers | Lung Cancer

Lung Cancer

Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung ...

Researchers Hope to Make Lung Cancer Screening a ‘Teachable Moment’

APRIL — A Georgetown University Medical Center researcher is launching a study she hopes will provide an opportunity for health care providers ...

TGen study identifies growth factor receptors that may prompt the spread of lung cancer

Preventing lung cancers from metastasizing to other parts of the body could provide benefit for patients against the leading cause of cancer death ... Full story

Study Identifies Potential Predictor of Clinical Outcome in Patients With Lung Cancer Treated With the Investigational Immunotherapy MK-3475

by AACR Communications Staff - SAN DIEGO — Among patients with non-small cell lung cancer (NSCLC) treated with the investigational immune checkpoint inhibitor MK-3475, those whose tumors had high levels of the protein PD-L1 had significantly better outcomes, according to results of a phase I clinical trial presented here at the AACR Annual Meeting 2014, April 5-9. ... Full story

Study identifies lung cancer patients likely to benefit from potential immune system-based therapy

In research to be presented at the AACR Annual Meeting 2014, investigators at Dana-Farber Cancer Institute report a promising way of predicting which patients with non-small cell lung cancer (NSCLC) are most likely to benefit from a drug that frees up an immune system attack on tumor cells. ... Full story

Lack of Insurance Coverage a Barrier to Lung Cancer Screening

Vast majority of current, former smokers willing to undergo spiral CT, Roswell Park/MUSC study finds ... Full story

Team Identifies Novel Biomarker for Head and Neck Cancer, Non-Small Cell Lung Cancer

JUPITER, FL – A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. ... Full story

Next-generation ALK Inhibitor Overcomes Resistance to Crizotinib in Lung Cancer

by AACR Communications Staff PHILADELPHIA —The targeted cancer drug crizotinib is very effective in causing rapid regression of a particular form of lung cancer, but patients’ tumors inevitably become resistant to the drug. ... Full story

Immunotherapy Data Heralds New Era of Lung Cancer Treatment

In the treatment of lung cancer, immunotherapy “has come of age and is here to stay” expert says at the 4th European Lung Cancer Conference ... Full story

Inherited mutated gene raises lung cancer risk for women, those who never smoked

DALLAS – People who have an inherited mutation of a certain gene have a high chance of getting lung cancer — higher, even, than heavy smokers with or without the inherited mutation, according to new findings by cancer researchers at UT Southwestern Medical Center. ... Full story

1 2 3 4 5 6 next total: 55 | displaying: 1 - 10